Leap Therapeutics Ownership | Who Owns Leap Therapeutics?

Leap Therapeutics Ownership Summary

Leap Therapeutics is owned by 18.63% institutional investors, 11.91% insiders, and 69.46% retail investors. Blackrock funding, inc. /de is the largest institutional shareholder, holding 5.65% of LPTX shares. Simplify Health Care ETF is the top mutual fund, with 2.02% of its assets in Leap Therapeutics shares.

LPTX Ownership Benchmark

Type	Name	% Inst	% Insiders	% Retail
Stock	Leap Therapeutics	18.63%	11.91%	69.46%
Sector	Healthcare Stocks	232.64%	10.66%	-143.30%
Industry	Biotech Stocks	382.13%	10.41%	-292.54%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

Holder	Shares	% Holding	Value
Blackrock funding, inc. /de	2.34M	5.65%	$2.72M
Vanguard group	2.13M	5.13%	$2.47M
Simplify asset management	1.87M	4.52%	$2.17M
Geode capital management	530.19K	1.28%	$615.23K
Group one trading	161.58K	0.39%	$187.43K
State street	125.61K	0.30%	$57.03K
Texas capital bank wealth management services	104.20K	0.25%	$120.87K
Two sigma advisers, lp	99.68K	0.24%	$45.26K
Key client fiduciary advisors	84.59K	0.20%	$98.12K
Citigroup	73.02K	0.18%	$84.71K

Top Institutional Shareholders by % of Total Assets

Holder	Shares	% Assets	Value
Simplify asset management	1.87M	0.04%	$2.17M
Key client fiduciary advisors	84.59K	0.03%	$98.12K
Texas capital bank wealth management services	104.20K	0.01%	$120.87K
Cnb bank	5.00K	0.00%	$5.80K
Adar1 capital management	25.83K	0.00%	$11.73K
Keystone financial group	11.71K	0.00%	$13.59K
Xtx topco	30.66K	0.00%	$13.92K
Optima capital	798.00	0.00%	$926.00
Group one trading	161.58K	0.00%	$187.43K
Sequoia financial advisors	48.00K	0.00%	$55.68K

Top Buyers

Holder	Shares	% Assets	Change
Blackrock funding, inc. /de	2.34M	-	2.22M
Vanguard group	2.13M	-	966.43K
Simplify asset management	1.87M	0.04%	896.71K
Geode capital management	530.19K	-	218.00K
Group one trading	161.58K	0.00%	157.77K

Top Sellers

Holder	Shares	% Assets	Change
Gilead sciences	-	-	-5.32M
Samsara biocapital	-	-	-2.44M
683 capital management	-	-	-1.44M
Point72 asset management	-	-	-1.40M
Rock springs capital management lp	-	-	-1.27M

New Positions

Holder	Shares	% Assets	Change	Value
Texas capital bank wealth management services	104.20K	0.01%	104.20K	$120.87K
Citigroup	73.02K	-	73.02K	$84.71K
Sequoia financial advisors	48.00K	0.00%	48.00K	$55.68K
Keystone financial group	11.71K	0.00%	11.71K	$13.59K
Optima capital	798.00	0.00%	798.00	$926.00

Sold Out

Holder	Change
Caldwell sutter capital	-4.00
Financial management professionals	-20.00
Newedge advisors	-82.00
Federation des caisses desjardins du quebec	-500.00
Us bancorp \de\	-610.00

Institutional Ownership Trends

Date	Holdings	Change %	Shares	Change %	Ownership	Change %	Increased Position	Change %	Decreased Position	Change %
Dec 31, 2025	26	-25.71%	7,722,557	-39.13%	18	1.99%	16	100.00%	5	-37.50%
Sep 30, 2025	24	-44.19%	11,035,559	-19.80%	26	2.40%	6	-62.50%	4	-60.00%
Jun 30, 2025	43	-8.51%	13,760,432	-17.57%	33	2.04%	16	-15.79%	10	-33.33%
Mar 31, 2025	47	-21.67%	16,693,179	-13.67%	40	1.53%	19	-44.12%	15	87.50%
Dec 31, 2024	60	25.00%	19,335,424	31.39%	51	4.04%	34	88.89%	8	-33.33%

Top Mutual Funds Shareholders

Holder	Shares	% Holding	Change
Simplify Health Care ETF	837.65K	2.02%	-19.71K
Vanguard US Total Market Shares ETF	754.74K	1.83%	-
Vanguard Total Stock Mkt Idx Inv	738.59K	1.78%	-16.14K
Vanguard Institutional Extnd Mkt Idx Tr	270.89K	0.65%	-123.44K
BIT Biotech Opportunities S	192.30K	0.47%	-
Fidelity Extended Market Index	168.34K	0.41%	-1.19K
BlackRock Extended Equity Market K	82.86K	0.22%	-35.00
BIT Global Leaders I - I	81.00K	0.20%	-
Extended Equity Market Fund K	80.38K	0.19%	-1.60K
iShares Micro-Cap ETF	61.84K	0.15%	-

Insider Transactions Trends

Date	Buy	Sell
2025 Q2	-	-
2025 Q1	-	-
2024 Q4	-	-
2024 Q2	-	-
2024 Q1	-	-

LPTX Ownership FAQ

Who Owns Leap Therapeutics?

Leap Therapeutics shareholders are primarily institutional investors at 18.63%, followed by 11.91% insiders and 69.46% retail investors. The average institutional ownership in Leap Therapeutics's industry, Biotech Stocks , is 382.13%, which Leap Therapeutics falls below.

Who owns the most shares of Leap Therapeutics?

Leap Therapeutics’s largest shareholders are Blackrock funding, inc. /de (2.34M shares, 5.65%), Vanguard group (2.13M shares, 5.13%), and Simplify asset management (1.87M shares, 4.52%). Together, they hold 15.30% of Leap Therapeutics’s total shares outstanding.

Does Blackrock own Leap Therapeutics?

BlackRock is not among the top 10 institutional shareholders of Leap Therapeutics.

Who is Leap Therapeutics’s biggest shareholder by percentage of total assets invested?

Simplify asset management is Leap Therapeutics’s biggest shareholder by percentage of total assets invested, with 0.04% of its assets in 1.87M Leap Therapeutics shares, valued at 2.17M$.

Who is the top mutual fund holder of Leap Therapeutics shares?

Simplify Health Care ETF is the top mutual fund holder of Leap Therapeutics shares, with 2.02% of its total shares outstanding invested in 837.65K Leap Therapeutics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis

Discover trending investment themes
Find your next best investment
Research stocks using tools